Linear Growth in Pediatric Renal Transplant Recipients Is Similar with Sirolimus vs. Calcineurin Inhibitors.

被引：0
|
作者：
Warshaw, Barry L. [1 ,2 ]
Hymes, Leonard C. [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Atlanta, GA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：341 / 342
页数：2
相关论文
共 50 条
  • [21] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function.
    Moneim, HA
    Flechner, SM
    George, P
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, D
    Novick, AC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 376 - 377
  • [22] Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients
    Nair, S
    Eason, J
    Loss, G
    LIVER TRANSPLANTATION, 2003, 9 (02) : 126 - 129
  • [23] Elimination of calcineurin inhibitors in paediatric renal transplant recipients
    Prytula, A. A.
    Dorresteijn, E.
    van Rooij, R.
    Keijzer-Veen, M. G.
    Cransberg, K.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1609 - 1609
  • [24] Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors
    Dubay, Derek
    Lilly, Leslie
    Smith, Robert
    Levy, Gory A.
    Therapondos, George
    HEPATOLOGY, 2007, 46 (04) : 495A - 495A
  • [25] Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients
    Chinnock, Timothy J.
    Shankel, Tamara
    Deming, Douglas
    Cutler, Drew
    Sahney, Shobha
    Fitts, James
    Chinnock, Richard E.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (07) : 746 - 749
  • [26] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [27] Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency
    Zuckermann, A.
    Keogh, A.
    Crespo-Leiro, M. G.
    Mancini, D.
    Gonzalez Vilchez, F.
    Almenar, L.
    Eisen, H.
    Tai, S. See
    Kushwaha, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S26 - S26
  • [28] Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients
    Potter, Brian J.
    Giannetti, Nadia
    Edwardes, Michael D. deB.
    Cecere, Renzo
    Cantarovich, Marcelo
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 305 - 308
  • [29] Effects of Conversion From Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplant Recipients
    Tsai, Kai-Fan
    Li, Lung-Chih
    Hsu, Chien-Ning
    Lin, Chih-Che
    Lin, Yu-Hung
    Cheng, Yu-Fan
    Wang, Chih-Chi
    Chen, Chao-Long
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 326 - 334
  • [30] Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol
    Schachter, AD
    Meyers, KE
    Spaneas, LD
    Palmer, JA
    Salmanullah, M
    Baluarte, J
    Brayman, KL
    Harmon, WE
    PEDIATRIC TRANSPLANTATION, 2004, 8 (02) : 171 - 177
12345